Skip to main content

Table 3 Bone marrow morphological and immunophenotypic characteristics

From: Characteristics of T-cell large granular lymphocyte proliferations associated with neutropenia and inflammatory arthropathy

Number

Cellularity

Type of infiltrate

Percentage of LGLs

Phenotype by IHC

Phenotype by flow cytometry

RCP

GP

Meg

LN

1

N

IC, IVL

35

3+, 4-, 8+, 57+, gr B+

2+, 3+, 4-, 5+, 7+/-↓, 8+, 16+/-, 56-, 57+

N

D, LSM

N

+

2

N

IC, IVL

30

3+, 4-, 8+, 57+, gr B+/-

ND

N

I, LSM

N

+

3

N

IC

50

3+, 4-, 8+, 57+/-, gr B+

2+, 3+, 4-, 5+/-↓, 7+, 8+, 16+/-, 56-, 57+, TCRαβ+, TCRγδ-

N

D, LSM

N

-

4

I

IC, IVL

58

ND

2+, 3+, 4-, 5-, 7+/-↓, 8+,16+/-, 56-, 57-, 43+↓, 25-, TCRαβ+, TCRγδ-, HLA-DR+/-

D

N, LSM

N

+

5a

D

IC, IVL

15

3+, 4-, 8-, 57+, gr B+/-

2+, 3+, 4-, 5+/-↓, 7+, 8-, 16+/-, 56+/-, 57-, 43+, 25-, TCRαβ-, TCRγδ+, HLA-DR+ and 2+, 3+, 4-, 5-, 7+, 8+/-, 16+, 56+/-, 57+, 43+, 25-, TCRαβ-, TCRγδ+, HLA-DR+

N

N, LSM

N

+

6

I

IC

40

3+, 4-, 8+, 57+, gr B+

ND

N

D, LSM

N

+

7

I

IC

80

3+, 4-, 8-/+, 57+/-, gr B+

2+, 3+, 4-, 5+, 7+/-↓, 8+/-, 16+/-, 56+/-, 57+, TCRαβ-, TCRγδ+, HLA-DR+/-

N

D, LSM

N

-

8

N

IC, IVL

25

3+, 4+, 8-, 57+, gr B+

ND

N

D, LSM

N

+

9

I

IC, IVL

35

3+, 4+, 8+, 57+, gr B+/-

ND

N

D, LSM

D

+

10

I

DI

15

3+, 4-, 8+, 57+/-, gr B+/-

2+, 3+, 4-, 5+, 7+, 8+, 16+/-, 56+/-, 57+/-, HLA-DR-/+

N

I, LSM

N

+

11

D

DI

15

3+, 4-, 8+, 57+/- gr B+/-

2+, 3+, 4-, 5+, 7+, 8+, 16+/-, 56-, 57+/-

N

D, LSM

N

-

12

I

IC, IVL

50

3+, 4-, 8+, 57+, gr B+

2+, 3+, 4-, 5+/-↓, 7+, 8+, 16+, 56+/-, 57+/-, 25-, HLA-DR+/-

N

D, LSM

N

+

13

D

IC, IVL

20

3+, 4-, 8+, 57+, gr B+

2+, 3+, 4-, 5+, 7-↓, 8+, 16+, 56-, 57+/-, 43+↓, 25-, TCRαβ+, TCRγδ-, HLA-DR+

D

N, LSM

N

-

14

I

IC

20

3+, 4-, 8+, 57-, gr B+/-

2+, 3+, 4-, 5+, 7+/-↓, 8+, 16+/-, 56-, 57-, 25-, TCRαβ+, TCRγδ-, HLA-DR+/-

D

N, LSM

N

-

15

I

IC, IVL

20

3+, 4-, 8+, 57-, gr B+

2+, 3+, 4-, 5-↓, 7-↓, 8+, 16+/-, 56-, 57-, 43+↓, 25-, TCRαβ+, TCRγδ-, HLA-DR+/-

N

D, LSM

N

+

16

N

IC, IVL

25

3+, 4-, 8+, 57+, gr B+/-

2+, 3+, 4-, 5-↓, 7-↓, 8+, 16+/-, 56-, TCRαβ+, TCRγδ-, HLA-DR+

N

D, LSM

N

+

17

D

IC, IVL

60

3+, 4-, 8+, 57+, gr B+

2+, 3+, 4-, 5-↓, 7-↓, 8+

N

D, LSM

N

-

18

I

IC, IVL

25

3+, 4-, 8+, 57+/-, gr B+

2+, 3+/-↓, 4-, 5+/-↓, 7+/-↓, 8+, 16+, 56-, 57+/-, 43+↓, 25-, TCRαβ+, TCRγδ-, HLA-DR+

N

N, LSM

N

-

19

I

IC

30

3+, 4-, 8+, 57+/-, gr B+

2+, 3+, 4-, 5+, 7+/-↓, 8+, 16+, 56-, 57+/-, 25-, TCRαβ+, TCRγδ-, HLA-DR+

D

N, LSM

D

+

20

D

IC, IVL

25

3+, 4-, 8+, 57+, gr B+

ND

D

N, LSM

N

+

21

I

IC, IVL

25

3+, 4-, 8+, 57+, gr B+

ND

N

D, LSM

N

+

  1. aTwo cell populations.
  2. Expression of antigens: -, lack of antigen expression; +/-, partial expression varying from 20% to 95% of cells; +, expression of antigens on 100% of cells; ↓, abnormal expression (dim, partial, or negative expression) and CD43 (weaker level). D, decreased; DI, dispersed; GP, granulocyte precursors; gr B, granzyme B; I, increased; IC, interstitial clusters; IHC, immunohistochemistry (phenotype in expression of CD markers); IVL, intravascular lymphocytes; LGLs, large granular lymphocytes; LN, lymphoid nodules; LSM, left-shifted maturation; Meg, megakaryocyte; N, normal; ND, not done; RCP, red cell precursors; TCR, T-cell receptor.